Early phases and First-in-Man clinical trials
Artialis teams with ATC pharma to offer a complete solution of clinical trials in the field of joint health, including first-in-man studies.
Canine serum Coll2-1 ELISA kit now available!
Explore cartilage degradation in dog using the Coll2-1 ELISA kit specifically designed for canine serum
Partnership with Nestlé
Artialis selected by Nestlé as premium partner for its clinical research in musculoskeletal disorders
We wanted to know whether oral treatment with polyphenols could decreased serum level of OA biomarkers in DMM mice model and needed results quickly. [Artialis has offered] robust skills, reactivity, and possibility to academic collaboration.
PhD candidate, INSERM U791, Laboratoire d'Ingénierie Ostéo-Articulaire et Dentaire (France)
We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice
Sales & Marketing Director, Tilman (Belgium)
“We chose Artialis because of their expertise in the design of in vivo protocol specialized in osteoarthritis. Moreover, it was very well written and Artialis team inspired a lot of confidence.
[We liked] their dedication to our project, their knowledge in osteoarthritis, their access to a state of the art animal facility, [and] their knowledge in in vivo design protocol (…) I would highly recommend the services of Artialis mainly for their high quality and high involvement.”
R&D Project Manager, Confidential Customer